Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may enhance the drug's ability to control blood levels, potentially offering greater outcomes for individuals with diabetes. Further study is underway to fully evaluate the long-term impact